FOR INFORMATION CONTACT:
Lori Gardner, Senior Director
Communications & Marketing
301.984.9496 ext. 226
For Immediate Release: March 7, 2012
Association of Community Cancer Centers to Honor Washington State Cancer Researcher and Community Oncologist
ROCKVILLE, Md.—Albert B. Einstein, Jr., MD, will be honored with the Association of Community Cancer Centers’ David King Community Clinical Scientist Award for his outstanding service, leadership, and commitment to the oncology community. Recently retired, Dr. Einstein was the executive director of the Swedish Cancer Institute in Seattle, Washington, and a medical oncologist.
The award will be presented at the ACCC 38th Annual National Meeting on Wednesday, March 14, 2012, in Baltimore, Md.
Dr. Einstein is nationally recognized for his work in cancer program development and chemotherapy for genitourinary cancers. He has been the principal investigator in numerous research studies and has been widely published on such topics as clinical research in the community setting, oncology economics, and cancer program development.
He practiced medical oncology for 17 years at the Virginia Mason Clinic, Seattle, where he was a member of the Executive Committee of the National Bladder Cancer Collaborative Group A, founder and principal investigator of the Virginia Mason Community Clinical Oncology Program (CCOP), chairperson for bladder cancer research for the Southwest Oncology Group Genitourinary Committee, president of the Virginia Mason Research Center, and medical director of the Virginia Mason cancer program.
In 1993 he returned to academic medicine as associate center director for clinical affairs at the H. Lee Moffitt Cancer Center and Research Institute, Tampa, Fla., during which time he helped to develop the center into a NCI-designated cancer center. In 1999 he returned to Seattle to establish and direct the Swedish Cancer Institute at the Swedish Medical Center, the largest comprehensive cancer program in the State of Washington.
He was co-director and member of the board of trustees of the Marsha Rivkin Ovarian Cancer Research Center. He is a past president of the Association of Community Cancer Centers, a past member of the National Cancer Legislation Advisory Committee, and a past member of the national Medicare Ambulatory Payment Classification Advisory Panel.
ACCC’s prestigious award is named after David K. King, MD, FACP, who passed away after a brief battle with cancer. Dr. King had a long and colorful history with the Association of Community Cancer Centers, serving in many capacities—president, chair of ACCC’s Annual Presidents' Retreat, and co-chair of ACCC’s reimbursement committee, just to name a few. Dr. King spent his entire life caring for individuals with cancer and advocating for access to quality care, while also championing the Community Clinical Oncology Program and the value of clinical research in the community setting.
David King Community Clinical Scientist Award winners become lifetime members of the ACCC National Academy of Community Oncology Scientists, which will serve as a valuable resource to ACCC, NCI, pharmaceutical companies, and other organizations involved in community cancer research.